Podcast Q&A: Cell & Gene Therapies
In this episode of tHEORetically Speaking, join Dr. Pamela Landsman-Blumberg, Amanda O’Hora, and Ajay Keshava from Magnolia Market Access, who answer questions from a recent webinar on how early stage planning taking into account commercial production, logistics, reimbursement, and health inequities can lead to successful approvals and market adoption.
Eli Lilly Settles Lawsuit with Minnesota to Cap Insulin Prices at $35 and Donate to Clinics
Eli Lilly has agreed to a settlement to provide low-cost insulin to Minnesota patients, addressing a [...]
House Hearing Addresses Drug Shortages and Manufacturing Challenges in the U.S.
At a House Ways and Means Committee hearing, the issue of chronic drug shortages in the [...]
ICER Report: Price Hikes for Eight Drugs Lead to $1.3 Billion Increase in U.S. Healthcare Costs
The Institute for Clinical and Economic Review (ICER) reported that price increases for eight drugs led [...]
NIH’s New Director Monica Bertagnolli Concerned about Obesity; Emphasizes the Importance of Clinical Trials and Role of Insurers in Healthcare Research
Newly appointed NIH director Monica Bertagnolli expressed her concern about obesity and highlighted the importance of [...]
Real-World Data Empowers Pharma Advertising: An Interview with PurpleLab CEO Mark Brosso
In a conversation with Mark Brosso, the CEO of PurpleLab, it was uncovered that the pharmaceutical [...]
U.S. Men’s Life Expectancy Gap Widens to Largest Since 1996 Amid Public Health Crises and Covid-19 Impact
The life expectancy of men in the U.S. is about six years shorter than women, according [...]
Changes in Health Insurance Cost Estimation Could Boost US Inflation Measures
Starting with the October consumer price index, the Bureau of Labor Statistics (BLS) is changing how [...]
Novo Nordisk Invests $6 Billion in API Production Expansion to Meet High Demand
Novo Nordisk is investing over $6 billion to expand Denmark's active pharmaceutical ingredients (API) production capacity. [...]
Eli Lilly to Release Weight Loss Drug Zepbound at a Discount, Poised for Fierce Competition with Novo Nordisk’s Wegovy
Eli Lilly's weight loss drug Zepbound is set to compete with Novo Nordisk's Wegovy. Zepbound, approved [...]
Eli Lilly’s Tirzepatide Receives FDA Approval for Obesity Treatment Under Brand Zepbound
Eli Lilly’s drug tirzepatide, branded as Mounjaro for type 2 diabetes, has gained FDA approval to [...]
Biogen Q3 Financials: Stable Revenues, Regulatory Success with Leqembi and Zurzuvae Amid Earnings Dip
Biogen has updated its financial outlook, indicating mixed results in its recent quarterly report. The company [...]
Long-lasting Impact of Childhood Gun Injuries on Survivors and Families and the Importance of Gun Safety Promotion
Firearms have been the leading cause of death among children and teens in the U.S. since [...]
Vertex Pharmaceuticals Misses Q3 Sales Estimates Due to Weak Demand for Older CF Treatments
Vertex Pharmaceuticals missed Wall Street estimates for Q3 sales, primarily due to weaker demand for older [...]
Navigating the Challenges of Real-World Data Management for Improving Patient Outcomes
Real-world data (RWD) and real-world evidence (RWE) can improve patient outcomes by optimizing clinical trials and [...]
ASN Kidney Week 2023: Studies Highlight Issues in CKD Diagnosis Delays and Management Using Real-World Data
Two posters presented at ASN Kidney Week 2023 analyzed real-world data on Chronic Kidney Disease (CKD) [...]
Transformative Role of Artificial Intelligence in Healthcare: Enhancing Patient Care, Clinical Research, Supply Chain Resiliency and Workforce Optimization
Artificial intelligence (AI) is transforming the healthcare industry in impactful ways. AI enables higher-quality patient care [...]
Robust Quarterly Earnings seen for Eli Lilly, Novo Nordisk, Moderna, and Regeneron Amid Success of Key Drugs
Eli Lilly, Novo Nordisk, Moderna, and Regeneron posted solid quarterly earnings due to the success of [...]
Updated ACS Lung Cancer Screening Guidelines: Redefining High-Risk Criteria, Expanding Age Range, and Easing Smoking History Requirements
The American Cancer Society (ACS) has updated its recommendations for lung cancer screening, dropping the criterion [...]
FDA Approves Novartis’ Cosentyx as First New Biologic HS Treatment in Decade: A Potential Rival for AbbVie’s Humira
The U.S. FDA has approved Novartis' Cosentyx (secukinumab) for treating moderate to severe hidradenitis suppurativa (HS), [...]
ImmunoACT’s NexCAR19 Becomes First Indigenous CAR-T Therapy Approved in India for B-cell Lymphomas and Leukemia Treatment
Immunoadoptive Cell Therapy Private Limited (ImmunoACT) has received approval from the Central Drug Standards Control Organisation [...]
Olympus Asks Healthcare Providers to Stop Using Its Insufflator Units Due to Over-Inflation Reports; FDA Issues Class I Recall
Olympus, a healthcare equipment company, has asked healthcare providers to stop using its UHI-4 insufflator unit, [...]
Biden Orders Healthcare Agencies to Develop Regulation Plan for AI Tools
President Biden has directed the Department of Health and Human Services and other leading health agencies [...]
Confirmatory Study for Sarepta and Roche’s Duchenne Gene Therapy Fails to Hit Primary Endpoint
Sarepta and Roche's confirmatory Phase III EMBARK study for Duchenne muscular dystrophy gene therapy, Elevidys, failed [...]
Ellen Cappellino Joins Klick Health to Enhance Value, Access, and Reimbursement Capabilities
Klick Health has announced that Ellen Cappellino, a market access professional, has joined the agency as [...]
